| abstract |
The present invention provides that at least one amino acid from a heavy chain constant region selected from the group consisting of amino acid residues 250, 314 and 428 is substituted with another amino acid different from that present in the unmodified antibody. Thus, IgG class modified antibodies are provided that have altered binding affinity for FcRn and / or serum half-life compared to unmodified antibodies. |